WishBone Medical Acquires Red Star Contract Manufacturing

By Julie A. Vetalice

WishBone Medical acquired Red Star, a contract manufacturer, to provide sterile packaging and plastic injection molded single-use instruments for the pediatric orthopaedic market.

Red Star Contract Manufacturing is an ISO 13485 Certified company located near Warsaw, Indiana. Its capabilities include insert injection molding, Class 8 clean room packaging, sterilization and fulfillment.

WishBone provides anatomically-appropriate implants and instruments in sterile-packed, single-use disposable kits. Its categories for product development include deformity correction, sports medicine, foot/ankle fractures, spine, biomaterials and single-use instruments. Chairman and CEO Nick Deeter commented, “We believe that single use, disposable kits are the future for orthopedics. Red Star can grow as WishBone Medical grows to provide these single use pediatric orthopedic products for kids.” Mr. Deeter added, “With this vertical integration of Red Star, we can insure [sic] we have access to this very important part of our supply chain.”

Scott Werstler, President of Red Star Contract Manufacturing, said, “We are excited Red Star is part of the WishBone Medical team providing these sterile packed products to help kids with orthopedic issues world-wide. Because of our work with WishBone Medical in completing all the sterilization validation and tooling for the most common instruments, Red Star will be able to provide other OEMs a turn-key solution to sterile-packed implants and instrumentation. We know the future of orthopedics is sterile packed single use products, like the rest of the healthcare industry, and we are well equipped and have the capacity to support it.”

Sources: WishBone Medical, Inc.; wishbonemedical.com

Recall from OEMs Continue Focus on Reducing Instruments in Operating Rooms in the October 2018 issue of BONEZONE®, orthopaedic companies are rethinking the number of instruments they provide for a producer in order to increase efficiency while reducing inventory costs and risks of cross-contamination.


Tags: M&A